BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, April 23, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Jan. 24, 2011
View Archived Issues
Crizotinib suppresses osteosarcoma and associated osteolytic/osteoblastic changes in vivo
Read More
Combination therapies including cediranib well tolerated in patients with gastric cancer
Read More
Parthenolide sensitizes osteosarcoma cells to radiation
Read More
Sonias tablet approved in Japan for type 2 diabetes
Read More
Febuxostat approved in Japan for gout
Read More
Longdaysin prolongs circadian rhythms in vitro and in vivo
Read More
New inhibitors of HCV NS5B identified at Vivalis
Read More
New inhibitors of heat shock protein HSP 90 presented
Read More
Mologen provides pipeline update
Read More
Chelsea Therapeutics reports data on Northera in neurogenic orthostatic hypotension
Read More
New inhibitors of hepatocyte growth factor receptor claimed
Read More
Florbetapir-PET imaging in patients with Alzheimer's disease
Read More
CHMP adopts positive opinion for Gilenya in relapsing-remitting MS
Read More
Vidaza approved in Japan for myelodysplastic syndromes
Read More
New prostanoid DP2 receptor antagonists discovered
Read More
Auris Medical advances phase IIb trial of AM-111 for acute sensorineural hearing loss
Read More
Pradaxa approved in Japan for prevention of stroke in atrial fibrillation
Read More
Novel beta-secretase 1 inhibitors developed at AstraZeneca
Read More
RiVax receives FDA orphan drug status for prevention of ricin intoxication
Read More
CHMP adopts final negative opinion for cladribine tablets in relapsing-remitting MS
Read More
CHMP recommends approval of Jevtana combination regimen for prostate cancer
Read More
CHMP decides against approval of Fampyra to improve walking in MS
Read More
CBLB-502 demonstrates direct anticancer effect in preclinical models
Read More
Romiplate IV injection approved in Japan for chronic ITP
Read More
Purdue Pharma launches Butrans transdermal system CIII in U.S. for chronic pain
Read More